In the News Pyrexar HT Hyperthermia

enfrdehija

new building introPyrexar Medical today purchased back all outstanding third party interest in the Utah based corporation.  

In April of 2015, Pyrexar Medical purchased the hyperthermia assets from Perseon Medical, which included the BSD-500 Superficial /Interstitial Hyperthermia System and the BSD-2000 Deep Regional Hyperthermia Systems.  In the original purchase agreement, Perseon Medical maintained a 19.9% interest in Pyrexar, along with royalties on future product sales.

In an agreement reached today, Pyrexar purchased back all Perseon held interests including all current and future royalty payments. “With the expected growth of Pyrexar Medical, we felt this was a great opportunity to retain full ownership of the company” said Pyrexar CEO, Mark Falkowski. “We should see significant return on this investment”.

ABOUT PYREXAR MEDICAL:
Pyrexar Medical is a pioneer and worldwide market leader in the development and manufacture of innovative and highly effective thermal therapy/hyperthermia treatment systems with established distribution and support networks around the world. PYREXAR Hyperthermia (PYREXAR HT) treatments, proven in multiple clinical trials over the last 30 years, increase the effective dose of ionizing radiation in solid tumors up to 3X without increasing toxicity to healthy tissues.
 
To find out more about Pyrexar Medical products, visit our webpage www.pyrexar.com

News Archive

  • PYREXAR Medical Acquires Hyperthermia Assets of BSD Medical +

    Promising Cancer Treatment Technology Now Under New Leadership Salt Lake Read More
  • Pyrexar Medical closes deal with HanBeam Technology +

    Hyperthermia products find distribution in South Korea Salt Lake City, Read More
  • Pyrexar Chief Scientist Goes to China +

    PYREXAR HT Hyperthermia products find distribution with Orientech SALT LAKE Read More
  • Pyrexar Medical expands Hyperthermia to Central Asia +

    PYREXAR HT Hyperthermia products find distribution with ORB Corporation SALT Read More
  • Pyrexar brings the Fight Against Cancer to South Korea +

    Pyrexar receives final authorization to sell Thermal Therapy devices in Read More
  • 1
  • 2
  • 3

Contact Info

We are pleased to hear from you. If we can help you with Pyrexar HT products, Clinical Studies or the Advancement of Hyperthermia. We would love to hear what you have to say.

Telephone

+1-(844)-797-3927


Address

1825 West Research Way, Ste E
Salt Lake City, UT 84119, USA

Spread the word about Hyperthermia.

facebooktwittergoogleplus
Contact Request
Thank you for contacting Pyrexar Medical.  Please let us know how we can assit you and we will reply at the first opportunity.
Contact Request
Thank you for your interest in the BSD-500 Superficial/Interstitial Hyperthermia System.  Please complete the form to receive your Brochure.
Contact Request
Thank you for your interest in the BSD-2000 Deep Regional Hyperthermia System.  Please complete the form to receive your Brochure.
Contact Request
Thank you for your interest in the BSD-2000 3D Deep Regional Hyperthermia System.  Please complete the form to receive your Brochure.
Contact Request
Thank you for your interest in the BSD-2000 3D/MR Deep Regional Hyperthermia System.  Please complete the form to receive your Brochure.